{
    "clinical_study": {
        "@rank": "90658", 
        "acronym": "BMACHC", 
        "arm_group": {
            "arm_group_label": "STEM CELL", 
            "arm_group_type": "Other", 
            "description": "Transfer of autologous Stem cell( MNCs) intrathecally"
        }, 
        "brief_summary": {
            "textblock": "This study is Single arm, Single Centre trial to check the Safety and Efficacy of Bone\n      Marrow Derived Autologous mononuclear cell {MNC} (100 Million per dose).trial to be\n      conducted for 36 months in patients with diabetes Mellitus in India,Primary outcome measure\n      are Improvement in cognitive and Psychiatric Symptoms and Improvement in Jerky,random, and\n      Uncontrollable Movements called Chorea."
        }, 
        "brief_title": "Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea.", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Huntington Disease", 
        "condition_browse": {
            "mesh_term": "Huntington Disease"
        }, 
        "detailed_description": {
            "textblock": "This study is Single arm, Single Centre trial study the Safety and Efficacy of Bone Marrow\n      Derived Autologous mononuclear cells (MNCs) ,to be conducted for 36 months in patients with\n      diabetes Mellitus in India,Primary outcome measure are Improvement in cognitive and\n      Psychiatric Symptoms and Improvement in Jerky,random, and Uncontrollable Movements called\n      Chorea."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient should suffer from Hunting tons Chorea,\n\n          -  Hunting tons chorea commonly become noticeable between the ages of 35 -44\n\n          -  Willingness to undergo Bone Marrow derived Autologous cell Therapy.\n\n          -  Ability to comprehend the explained protocol and thereafter give an informed consent\n             as well as sign the required Informed Consent form(ICF) for the study.\n\n          -  Ability and willingness to regular visit to hospital for protocol procedures and\n             follow up\n\n        Exclusion Criteria:\n\n          -  Patient with History of Immunodeficiency HIV+,Hepatitis B virus ( HBV) and History of\n             Life threatening allergic or immune -Mediated Reaction. the site of bone marrow\n             aspiration potentially limiting Procedure.\n\n          -  alcohol and drug abuse / dependence.\n\n          -  Severe skin infection.\n\n          -  Haemodynamically unstable.\n\n             =subject with primary and secondary diabetes , Insulin dependence.\n\n          -  Neurological disease caused by autoimmune or genetic cause.\n\n          -  patients suffering from peripheral muscular dystrophy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "44 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01834053", 
            "org_study_id": "00106"
        }, 
        "intervention": {
            "arm_group_label": "STEM CELL", 
            "description": "Intrathecal transplantation of autologous 100 millions Stem cells{MNCs } per dose'", 
            "intervention_name": "autologous Stem Cell", 
            "intervention_type": "Biological", 
            "other_name": "Intrathecal transplantation of autologous MNCs"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Huntington Disease,stem cell therapy", 
        "lastchanged_date": "April 15, 2013", 
        "location": {
            "contact": {
                "email": "sac2751982@gmail.com", 
                "last_name": "Sachin P Jamadar, D ORTHO", 
                "phone": "+918888788880"
            }, 
            "contact_backup": {
                "email": "drsmitabhoyar@rediffmail.com", 
                "last_name": "Smita S Bhoyar, B AMS PGCR", 
                "phone": "9372620569"
            }, 
            "facility": {
                "address": {
                    "city": "Pune", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "411009"
                }, 
                "name": "Chaitanya Hospital"
            }, 
            "investigator": {
                "last_name": "Anant E Bagul, MS", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "Safety and Efficacy of Bone Marrow Derived MNCs for the Treatment of Huntingtons Chorea.", 
        "overall_contact": {
            "email": "sac2751982@gmail.com", 
            "last_name": "Sachin P Jamadar, D Ortho", 
            "phone": "+918888788880"
        }, 
        "overall_contact_backup": {
            "email": "drsmitabhoyar@rediff.com", 
            "last_name": "Smita S Bhoyar, B.A.M.S.PGCR", 
            "phone": "9372620569"
        }, 
        "overall_official": {
            "affiliation": "CHAITANYA HOSPITAL", 
            "last_name": "ANANT E BAGUL, M.S", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Improvement in Cognitive and psychiatric symptoms", 
            "safety_issue": "Yes", 
            "time_frame": "6 Months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01834053"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chaitanya Hospital, Pune", 
            "investigator_full_name": "Dr. Sachin Jamadar", 
            "investigator_title": "CO-Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Improvement in neuropsychiatric behaviour", 
                "safety_issue": "Yes", 
                "time_frame": "6 Months"
            }, 
            {
                "description": "Increase in life expectancy.Time period- 6 Months", 
                "measure": "Increase in life expectancy", 
                "safety_issue": "Yes", 
                "time_frame": "6 Months"
            }, 
            {
                "description": "-Improvement in writhing motions or abnormal posturing", 
                "measure": "Improvement in writhing motions or abnormal posturing", 
                "safety_issue": "Yes", 
                "time_frame": "6 month"
            }, 
            {
                "measure": "Improvement in compulsive behaviour", 
                "safety_issue": "Yes", 
                "time_frame": "6 month"
            }
        ], 
        "source": "Chaitanya Hospital, Pune", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chaitanya Hospital, Pune", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}